HEADER UNKNOWN FUNCTION 19-JUN-15 2N4J TITLE SOLUTION STRUCTURE OF A SELF COMPLEMENTARY XYLONUCLEIC ACID DUPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: XNA (5'-R(*(8XG)P*(8XU)P*(8XG)P*(8XU)P*(8XA)P*(8XC)P*(8XA) COMPND 3 P*(8XC))-3'); COMPND 4 CHAIN: A, B; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS UNKNOWN FUNCTION EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR M.MAITI,E.LESCRINIER,P.HERDEWIJN REVDAT 2 16-SEP-15 2N4J 1 JRNL REVDAT 1 29-JUL-15 2N4J 0 JRNL AUTH M.MAITI,M.MAITI,C.KNIES,S.DUMBRE,E.LESCRINIER,H.ROSEMEYER, JRNL AUTH 2 A.CEULEMANS,P.HERDEWIJN JRNL TITL XYLONUCLEIC ACID: SYNTHESIS, STRUCTURE, AND ORTHOGONAL JRNL TITL 2 PAIRING PROPERTIES. JRNL REF NUCLEIC ACIDS RES. V. 43 7189 2015 JRNL REFN ISSN 0305-1048 JRNL PMID 26175047 JRNL DOI 10.1093/NAR/GKV719 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR_NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2N4J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JUL-15. REMARK 100 THE RCSB ID CODE IS RCSB104412. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 283 REMARK 210 PH : 7.2 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.5 MM XNA, 100% D2O; 1.5 MM REMARK 210 XNA, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D DQF-COSY; 2D 1H-1H TOCSY; 2D REMARK 210 1H-1H NOESY; 2D 1H-13C HSQC REMARK 210 ALIPHATIC; 2D 1H-13C HSQC REMARK 210 AROMATIC; 2D 1H-13C HMBC REMARK 210 AROMATIC; 2D 1H-31P COSY; 31P REMARK 210 DEC. 2D DQF-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 2.1, CARA REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS, REMARK 210 MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H3 8XU A 2 N1 8XA B 15 1.55 REMARK 500 N3 8XC A 8 H1 8XG B 9 1.55 REMARK 500 H1 8XG A 1 N3 8XC B 16 1.56 REMARK 500 N1 8XA A 7 H3 8XU B 10 1.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 25669 RELATED DB: BMRB DBREF 2N4J A 1 8 PDB 2N4J 2N4J 1 8 DBREF 2N4J B 9 16 PDB 2N4J 2N4J 9 16 SEQRES 1 A 8 8XG 8XU 8XG 8XU 8XA 8XC 8XA 8XC SEQRES 1 B 8 8XG 8XU 8XG 8XU 8XA 8XC 8XA 8XC HET 8XG A 1 32 HET 8XU A 2 30 HET 8XG A 3 34 HET 8XU A 4 30 HET 8XA A 5 33 HET 8XC A 6 31 HET 8XA A 7 33 HET 8XC A 8 32 HET 8XG B 9 32 HET 8XU B 10 30 HET 8XG B 11 34 HET 8XU B 12 30 HET 8XA B 13 33 HET 8XC B 14 31 HET 8XA B 15 33 HET 8XC B 16 32 HETNAM 8XG 2-AMINO-9-(5-O-PHOSPHONO-BETA-D-XYLOFURANOSYL)-1,9- HETNAM 2 8XG DIHYDRO-6H-PURIN-6-ONE HETNAM 8XU 1-(5-O-PHOSPHONO-BETA-D-XYLOFURANOSYL)PYRIMIDINE-2, HETNAM 2 8XU 4(1H,3H)-DIONE HETNAM 8XA 9-(5-O-PHOSPHONO-BETA-D-XYLOFURANOSYL)-9H-PURIN-6-AMINE HETNAM 8XC 4-AMINO-1-(5-O-PHOSPHONO-BETA-D-XYLOFURANOSYL) HETNAM 2 8XC PYRIMIDIN-2(1H)-ONE FORMUL 1 8XG 4(C10 H14 N5 O8 P) FORMUL 1 8XU 4(C9 H13 N2 O9 P) FORMUL 1 8XA 4(C10 H14 N5 O7 P) FORMUL 1 8XC 4(C9 H14 N3 O8 P) LINK O3' 8XG A 1 P 8XU A 2 1555 1555 1.61 LINK O3' 8XU A 2 P 8XG A 3 1555 1555 1.61 LINK O3' 8XG A 3 P 8XU A 4 1555 1555 1.62 LINK O3' 8XU A 4 P 8XA A 5 1555 1555 1.61 LINK O3' 8XA A 5 P 8XC A 6 1555 1555 1.62 LINK O3' 8XC A 6 P 8XA A 7 1555 1555 1.62 LINK O3' 8XA A 7 P 8XC A 8 1555 1555 1.62 LINK O3' 8XG B 9 P 8XU B 10 1555 1555 1.62 LINK O3' 8XU B 10 P 8XG B 11 1555 1555 1.61 LINK O3' 8XG B 11 P 8XU B 12 1555 1555 1.61 LINK O3' 8XU B 12 P 8XA B 13 1555 1555 1.62 LINK O3' 8XA B 13 P 8XC B 14 1555 1555 1.62 LINK O3' 8XC B 14 P 8XA B 15 1555 1555 1.62 LINK O3' 8XA B 15 P 8XC B 16 1555 1555 1.62 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 86 0 16 0 0 0 0 6 0 0 0 2 END